More on CIRM's Restriction of Info on Biotech Applicants
The California stem cell agency says its brief statement this week on restriction of information involving biotech companies was generated in an effort to offer a public explanation of its policy.
In response to a query about what led to the statement, Maria Bonneville, executive director of the CIRM board, said,
"In light of CIRM's efforts to work with …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.